Current Neuropharmacology

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Back Subscribe
Review Article

Advancing Alzheimer's Diagnosis with AI-Enhanced MRI: A Review of Challenges and Implications

Author(s): Zahra Batool, ShanShan Hu, Mohammad Amjad Kamal*, Nigel H. Greig and Bairong Shen*

Volume 23, Issue 14, 2025

Published on: 30 July, 2025

Page: [1860 - 1877] Pages: 18

DOI: 10.2174/011570159X353595250303064846

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Neurological disorders are marked by neurodegeneration, leading to impaired cognition, psychosis, and mood alterations. These symptoms are typically associated with functional changes in both emotional and cognitive processes, which are often correlated with anatomical variations in the brain. Hence, brain structural magnetic resonance imaging (MRI) data have become a critical focus in research, particularly for predictive modeling. The involvement of large MRI data consortia, such as the Alzheimer's Disease Neuroimaging Initiative (ADNI), has facilitated numerous MRI-based classification studies utilizing advanced artificial intelligence models. Among these, convolutional neural networks (CNNs) and non-convolutional artificial neural networks (NC-ANNs) have been prominently employed for brain image processing tasks. These deep learning models have shown significant promise in enhancing the predictive performance for the diagnosis of neurological disorders, with a particular emphasis on Alzheimer's disease (AD). This review aimed to provide a comprehensive summary of these deep learning studies, critically evaluating their methodologies and outcomes. By categorizing the studies into various sub-fields, we aimed to highlight the strengths and limitations of using MRI-based deep learning approaches for diagnosing brain disorders. Furthermore, we discussed the potential implications of these advancements in clinical practice, considering the challenges and future directions for improving diagnostic accuracy and patient outcomes. Through this detailed analysis, we seek to contribute to the ongoing efforts in harnessing AI for better understanding and management of AD.

Keywords: Artificial Intelligence, Alzheimer's disease, neurodegeneration, magnetic resonance imaging, deep learning models, convolution neural networks (CNNs), impaired cognition.

Graphical Abstract

[1]
Gitler, A.D.; Dhillon, P.; Shorter, J. Neurodegenerative disease: Models, mechanisms, and a new hope. Dis. Model. Mech., 2017, 10(5), 499-502.
[http://dx.doi.org/10.1242/dmm.030205] [PMID: 28468935]
[2]
Fumia, A.; Nicola, C.; Marco, G.; Noemi, N.; Alessio, A. Role of nutraceuticals on neurodegenerative diseases: Neuroprotective and immunomodulant activity. Nat. Prod. Res., 2021, 5(2), 5916-5933.
[http://dx.doi.org/10.1080/14786419.2021.2020265] [PMID: 34963389]
[3]
Sharma, P.; Srivastava, P.; Seth, A.; Tripathi, P.N.; Banerjee, A.G.; Shrivastava, S.K. Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies. Prog. Neurobiol., 2019, 174, 53-89.
[http://dx.doi.org/10.1016/j.pneurobio.2018.12.006] [PMID: 30599179]
[4]
Maia, M.A.; Sousa, E. BACE-1 and γ-secretase as therapeutic targets for Alzheimer’s Disease. Pharmaceuticals (Basel), 2019, 12(1), 41.
[http://dx.doi.org/10.3390/ph12010041] [PMID: 30893882]
[5]
Patterson, C. World Alzheimer report; Published by Alzheimer’s Disease International; ADI: London, 2018, pp. 1-42.
[6]
Prince, M.; Wimo, A.; Guerchet, M.; Ali, G.C.; Yu-Tzu, W.; Matthew, P. Alzheimer’s Disease International. World Alzheimer Report 2015. The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International, 2019. Aviailable from: https://www.alzint.org/u/WorldAlzheimerReport2015.pdf
[7]
Heemels, M.T. Neurodegenerative diseases. Nature, 2016, 539(7628), 179.
[http://dx.doi.org/10.1038/539179a] [PMID: 27830810]
[8]
Taylor, J.P.; Brown, R.H., Jr; Cleveland, D.W. Decoding ALS: From genes to mechanism. Nature, 2016, 539(7628), 197-206.
[http://dx.doi.org/10.1038/nature20413] [PMID: 27830784]
[9]
Fujii, T.; Mashimo, M.; Moriwaki, Y.; Misawa, H.; Ono, S.; Horiguchi, K.; Kawashima, K. Expression and function of the cholinergic system in immune cells. Front. Immunol., 2017, 8, 1085.
[http://dx.doi.org/10.3389/fimmu.2017.01085] [PMID: 28932225]
[10]
Zaccone, D.; Icardo, J.M.; Kuciel, M.; Alesci, A.; Pergolizzi, S.; Satora, L.; Lauriano, E.R.; Zaccone, G. Polymorphous granular cells in the lung of the primitive fish, the bichir. Polypterus senegalus. Acta Zool., 2017, 98(1), 13-19.
[http://dx.doi.org/10.1111/azo.12145]
[11]
Jacobson, A.; Yang, D.; Vella, M.; Chiu, I.M. The intestinal neuro-immune axis: Crosstalk between neurons, immune cells, and microbes. Mucosal Immunol., 2021, 14(3), 555-565.
[http://dx.doi.org/10.1038/s41385-020-00368-1] [PMID: 33542493]
[12]
Reitz, C.; Mayeux, R. Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem. Pharmacol., 2014, 88(4), 640-651.
[http://dx.doi.org/10.1016/j.bcp.2013.12.024] [PMID: 24398425]
[13]
Rehman, M.U.; Sehar, N.; Rasool, I.; Aldossari, R.M.; Wani, A.B.; Rashid, S.M.; Wali, A.F.; Ali, A.; Arafah, A.; Khan, A. Glymphatic pathway: An emerging perspective in the pathophysiology of neurodegenerative diseases. Int. J. Geriatr. Psychiatry, 2024, 39(6), e6104.
[http://dx.doi.org/10.1002/gps.6104] [PMID: 38877354]
[14]
Hampel, H.; Hardy, J.; Blennow, K.; Chen, C.; Perry, G.; Kim, S.H.; Villemagne, V.L.; Aisen, P.; Vendruscolo, M.; Iwatsubo, T.; Masters, C.L.; Cho, M.; Lannfelt, L.; Cummings, J.L.; Vergallo, A. The amyloid-β pathway in Alzheimer’s disease. Mol. Psychiatry, 2021, 26(10), 5481-5503.
[http://dx.doi.org/10.1038/s41380-021-01249-0] [PMID: 34456336]
[15]
Dhapola, R.; Beura, S.K.; Sharma, P.; Singh, S.K. Oxidative stress in Alzheimer’s disease: Current knowledge of signaling pathways and therapeutics. Mol. Biol. Rep., 2024, 51(1), 48.
[http://dx.doi.org/10.1007/s11033-023-09021-z] [PMID: 38165499]
[16]
Cheignon, C.; Tomas, M.; Bonnefont-Rousselot, D.; Faller, P.; Hureau, C.; Collin, F. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol., 2018, 14, 450-464.
[http://dx.doi.org/10.1016/j.redox.2017.10.014] [PMID: 29080524]
[17]
Firdous, S.M.; Khan, S.A.; Maity, A. Oxidative stress–mediated neuroinflammation in Alzheimer’s disease. Naunyn Schmiedebergs Arch. Pharmacol., 2024, 397(11), 8189-8209.
[http://dx.doi.org/10.1007/s00210-024-03188-3] [PMID: 38832985]
[18]
Bai, R.; Guo, J.; Ye, X.Y.; Xie, Y.; Xie, T. Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease. Ageing Res. Rev., 2022, 77, 101619.
[http://dx.doi.org/10.1016/j.arr.2022.101619] [PMID: 35395415]
[19]
Yoo, S.M.; Park, J.; Kim, S.H.; Jung, Y.K. Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer’s disease. BMB Rep., 2020, 53(1), 35-46.
[http://dx.doi.org/10.5483/BMBRep.2020.53.1.274] [PMID: 31818363]
[20]
Yen, C.; Lin, C.L.; Chiang, M.C. Exploring the frontiers of neuroimaging: A review of recent advances in understanding brain functioning and disorders. Life (Basel), 2023, 13(7), 1472.
[http://dx.doi.org/10.3390/life13071472] [PMID: 37511847]
[21]
Kaskikallio, A.; Karrasch, M.; Koikkalainen, J.; Lötjönen, J.; Rinne, J.O.; Tuokkola, T.; Parkkola, R.; Grönholm-Nyman, P. White matter hyperintensities and cognitive impairment in healthy and pathological aging: A quantified brain MRI study. Dement. Geriatr. Cogn. Disord., 2019, 48(5-6), 297-307.
[http://dx.doi.org/10.1159/000506124] [PMID: 32209796]
[22]
Banerjee, G.; Jang, H.; Kim, H.J.; Kim, S.T.; Kim, J.S.; Lee, J.H. Im, K.; Kwon, H.; Lee, J.M.; Na, D.L.; Seo, S.W.; Werring, D.J. Total MRI small vessel disease burden correlates with cognitive performance, cortical atrophy, and network measures in a memory clinic population. J. Alzheimers Dis., 2018, 63(4), 1485-1497.
[http://dx.doi.org/10.3233/JAD-170943] [PMID: 29843234]
[23]
Grajauskas, L.A.; Guo, H.; D’Arcy, R.C.N.; Song, X. Toward MRI ‐based whole‐brain health assessment: The brain atrophy and lesion index (BALI). Aging Med. (Milton), 2018, 1(1), 55-63.
[http://dx.doi.org/10.1002/agm2.12014] [PMID: 31942481]
[24]
Rittman, T. Neurological update: Neuroimaging in dementia. J. Neurol., 2020, 267(11), 3429-3435.
[http://dx.doi.org/10.1007/s00415-020-10040-0] [PMID: 32638104]
[25]
Dallas, P.V.; Michael, W.; Weiner, L.A.; Charles, D.C.; Robert, C. Using the Alzheimer’s Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer’s disease. Alzheimers Dement., 2022, 18(4), 824-857.
[http://dx.doi.org/10.1002/alz.12422] [PMID: 34581485]
[26]
Weiner, M.W.; Veitch, D.P.; Aisen, P.S.; Beckett, L.A.; Cairns, N.J.; Green, R.C.; Harvey, D.; Jack, C.R., Jr; Jagust, W.; Morris, J.C.; Petersen, R.C.; Salazar, J.; Saykin, A.J.; Shaw, L.M.; Toga, A.W.; Trojanowski, J.Q. The Alzheimer’s disease neuroimaging initiative 3: Continued innovation for clinical trial improvement. Alzheimers Dement., 2017, 13(5), 561-571.
[http://dx.doi.org/10.1016/j.jalz.2016.10.006] [PMID: 27931796]
[27]
Bacon, E.J.; He, D.; Achi, N.A.D.; Wang, L.; Li, H.; Yao-Digba, P.D.Z.; Monkam, P.; Qi, S. Neuroimage analysis using artificial intelligence approaches: A systematic review. Med. Biol. Eng. Comput., 2024, 62(9), 2599-2627.
[http://dx.doi.org/10.1007/s11517-024-03097-w] [PMID: 38664348]
[28]
Surianarayanan, C.; Lawrence, J.J.; Chelliah, P.R.; Prakash, E.; Hewage, C. Convergence of artifcial intelligence and neuroscience towards the diagnosis of neurological disorders—a scoping review. Sensors (Basel), 2023, 23(6), 3062.
[http://dx.doi.org/10.3390/s23063062] [PMID: 36991773]
[29]
Elliott, M.L. MRI-based biomarkers of accelerated aging and dementia risk in midlife: How close are we? Ageing Res. Rev., 2020, 61, 101075.
[http://dx.doi.org/10.1016/j.arr.2020.101075] [PMID: 32325150]
[30]
Jo, T.; Nho, K.; Saykin, A.J. Deep learning in Alzheimer’s disease: Diagnostic classification and prognostic prediction using neuroimaging data. Front. Aging Neurosci., 2019, 11(220), 220.
[http://dx.doi.org/10.3389/fnagi.2019.00220] [PMID: 31481890]
[31]
Dona, O.; Thompson, J.; Druchok, C. Comprehensive review on magnetic resonance imaging in Alzheimer’s disease. Crit. Rev. Biomed. Eng., 2016, 44(3), 213-225.
[http://dx.doi.org/10.1615/CritRevBiomedEng.2016019544] [PMID: 28605353]
[32]
Mateos-Pérez, J.M.; Dadar, M.; Lacalle-Aurioles, M.; Iturria-Medina, Y.; Zeighami, Y.; Evans, A.C. Structural neuroimaging as clinical predictor: A review of machine learning applications. Neuroimage Clin., 2018, 20, 506-522.
[http://dx.doi.org/10.1016/j.nicl.2018.08.019] [PMID: 30167371]
[33]
Jiang, J.; Liu, T.; Zhu, W.; Koncz, R.; Liu, H.; Lee, T.; Sachdev, P.S.; Wen, W. UBO Detector – A cluster-based, fully automated pipeline for extracting white matter hyperintensities. Neuroimage, 2018, 174, 539-549.
[http://dx.doi.org/10.1016/j.neuroimage.2018.03.050] [PMID: 29578029]
[34]
Pini, L.; Pievani, M.; Bocchetta, M.; Altomare, D.; Bosco, P.; Cavedo, E.; Galluzzi, S.; Marizzoni, M.; Frisoni, G.B. Brain atrophy in Alzheimer’s Disease and aging. Ageing Res. Rev., 2016, 30, 25-48.
[http://dx.doi.org/10.1016/j.arr.2016.01.002] [PMID: 26827786]
[35]
Khalifa, M.; Albadawy, M. AI in diagnostic imaging: Revolutionising accuracy and efficiency. Comput. Methods Programs Biomed. Update, 2024, 5, 100146.
[http://dx.doi.org/10.1016/j.cmpbup.2024.100146]
[36]
Jiao, Z.; Lai, Y.; Kang, J.; Gong, W.; Ma, L.; Jia, T.; Xie, C.; Xiang, S.; Cheng, W.; Heinz, A.; Desrivières, S.; Schumann, G. A model-based approach to assess reproducibility for large-scale high-throughput MRI-based studies. Neuroimage, 2022, 255, 119166.
[http://dx.doi.org/10.1016/j.neuroimage.2022.119166] [PMID: 35398282]
[37]
Despotović, I.; Goossens, B.; Philips, W. MRI segmentation of the human brain: Challenges, methods, and applications. Comput. Math. Methods Med., 2015, 2015, 1-23.
[http://dx.doi.org/10.1155/2015/450341] [PMID: 25945121]
[38]
Kale, M.; Wankhede, N.; Pawar, R.; Ballal, S.; Kumawat, R.; Goswami, M.; Khalid, M.; Taksande, B.; Upaganlawar, A.; Umekar, M.; Kopalli, S.R.; Koppula, S. AI-driven innovations in Alzheimer’s disease: Integrating early diagnosis, personalized treatment, and prognostic modelling. Ageing Res. Rev., 2024, 101, 102497.
[http://dx.doi.org/10.1016/j.arr.2024.102497] [PMID: 39293530]
[39]
Hassija, V.; Chamola, V.; Mahapatra, A.; Singal, A.; Goel, D.; Huang, K.; Scardapane, S.; Spinelli, I.; Mahmud, M.; Hussain, A. Interpreting black-box models: A review on explainable artificial intelligence. Cognit. Comput., 2024, 16(1), 45-74.
[http://dx.doi.org/10.1007/s12559-023-10179-8]
[40]
AbdelAziz, N.M.; Said, W.; AbdelHafeez, M.M.; Ali, A.H. Advanced interpretable diagnosis of Alzheimer’s disease using SECNN-RF framework with explainable AI. Front. Artif. Intell., 2024, 7, 1456069.
[http://dx.doi.org/10.3389/frai.2024.1456069] [PMID: 39286548]
[41]
Ersavas, T.; Smith, M.A.; Mattick, J.S. Novel applications of convolutional neural networks in the age of transformers. Sci. Rep., 2024, 14(1), 10000.
[http://dx.doi.org/10.1038/s41598-024-60709-z] [PMID: 38693215]
[42]
Garg, N.; Choudhry, M.S.; Bodade, R.M. A review on Alzheimer’s disease classification from normal controls and mild cognitive impairment using structural MR images. J. Neurosci. Methods, 2023, 384, 109745.
[http://dx.doi.org/10.1016/j.jneumeth.2022.109745] [PMID: 36395961]
[43]
El-Assy, A.M.; Amer, H.M.; Ibrahim, H.M.; Mohamed, M.A. A novel CNN architecture for accurate early detection and classification of Alzheimer’s disease using MRI data. Sci. Rep., 2024, 14(1), 3463.
[http://dx.doi.org/10.1038/s41598-024-53733-6] [PMID: 38342924]
[44]
Ghafoorian, M.; Karssemeijer, N.; Heskes, T.; Bergkamp, M.; Wissink, J.; Obels, J.; Keizer, K.; Leeuw, F-E.; Ginneken, B.; Marchiori, E.; Platel, B. Deep multi-scale location-aware 3D convolutional neural networks for automated detection of lacunes of presumed vascular origin. Neuroimage Clin., 2017, 14, 391-399.
[http://dx.doi.org/10.1016/j.nicl.2017.01.033] [PMID: 28271039]
[45]
Puente-Castro, A.; Fernandez-Blanco, E.; Pazos, A.; Munteanu, C.R. Automatic assessment of Alzheimer’s disease diagnosis based on deep learning techniques. Comput. Biol. Med., 2020, 120, 103764.
[http://dx.doi.org/10.1016/j.compbiomed.2020.103764] [PMID: 32421658]
[46]
Kruthika, K.R.; Rajeswari, M.H.D.; Maheshappa, H.D. CBIR system using Capsule Networks and 3D CNN for Alzheimer’s disease diagnosis. Inform. Med. Unlocked, 2019, 14, 59-68.
[http://dx.doi.org/10.1016/j.imu.2018.12.001]
[47]
Huang, Y.; Xu, J.; Zhou, Y.; Tong, T.; Zhuang, X. Diagnosis of Alzheimer’s disease via multi-modality 3D convolutional neural network. Front. Neurosci., 2019, 13, 509.
[http://dx.doi.org/10.3389/fnins.2019.00509] [PMID: 31213967]
[48]
Basheera, S.; Sai, R.M.S. Convolution neural network–based Alzheimer’s disease classification using hybrid enhanced independent component analysis based segmented gray matter of T2 weighted magnetic resonance imaging with clinical valuation. Alzheimers Dement. (N. Y.), 2019, 5(1), 974-986.
[http://dx.doi.org/10.1016/j.trci.2019.10.001] [PMID: 31921971]
[49]
Jonsson, B.A.; Bjornsdottir, G.; Thorgeirsson, T.E.; Ellingsen, L.M.; Walters, G.B.; Gudbjartsson, D.F.; Stefansson, H.; Stefansson, K.; Ulfarsson, M.O. Brain age prediction using deep learning uncovers associated sequence variants. Nat. Commun., 2019, 10(1), 5409.
[http://dx.doi.org/10.1038/s41467-019-13163-9] [PMID: 31776335]
[50]
Bashyam, V.M.; Erus, G.; Doshi, J.; Habes, M.; Nasrallah, I.M.; Truelove-Hill, M.; Srinivasan, D.; Mamourian, L.; Pomponio, R.; Fan, Y.; Launer, L.J.; Masters, C.L.; Maruff, P.; Zhuo, C.; Völzke, H.; Johnson, S.C.; Fripp, J.; Koutsouleris, N.; Satterthwaite, T.D.; Wolf, D.; Gur, R.E.; Gur, R.C.; Morris, J.; Albert, M.S.; Grabe, H.J.; Resnick, S.; Bryan, R.N.; Wolk, D.A.; Shou, H.; Davatzikos, C. MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide. Brain, 2020, 143(7), 2312-2324.
[http://dx.doi.org/10.1093/brain/awaa160] [PMID: 32591831]
[51]
Bae, J.B.; Lee, S.; Jung, W.; Park, S.; Kim, W.; Oh, H.; Han, J.W.; Kim, G.E.; Kim, J.S.; Kim, J.H.; Kim, K.W. Identification of Alzheimer’s disease using a convolutional neural network model based on T1-weighted magnetic resonance imaging. Sci. Rep., 2020, 10(1), 22252.
[http://dx.doi.org/10.1038/s41598-020-79243-9] [PMID: 33335244]
[52]
Odimayo, S.; Olisah, C.C.; Mohammed, K. Structure focused neurodegeneration convolutional neural network for modelling and classification of Alzheimer’s disease. Sci. Rep., 2024, 14(1), 15270.
[http://dx.doi.org/10.1038/s41598-024-60611-8] [PMID: 38961114]
[53]
Wang, S.H.; Phillips, P.; Sui, Y.; Liu, B.; Yang, M.; Cheng, H. Classification of Alzheimer’s disease based on eight-layer convolutional neural network with leaky rectified linear unit and max pooling. J. Med. Syst., 2018, 42(5), 85.
[http://dx.doi.org/10.1007/s10916-018-0932-7] [PMID: 29577169]
[54]
Pan, D.; Zeng, A.; Jia, L.; Huang, Y.; Frizzell, T.; Song, X. Early detection of Alzheimer’s disease using magnetic resonance imaging: A novel approach combining convolutional neural networks and ensemble learning. Front. Neurosci., 2020, 14, 259.
[http://dx.doi.org/10.3389/fnins.2020.00259] [PMID: 32477040]
[55]
Basaia, S.; Agosta, F.; Wagner, L.; Canu, E.; Magnani, G.; Santangelo, R.; Filippi, M. Automated classification of Alzheimer’s disease and mild cognitive impairment using a single MRI and deep neural networks. Neuroimage Clin., 2019, 21, 101645.
[http://dx.doi.org/10.1016/j.nicl.2018.101645] [PMID: 30584016]
[56]
Cohen, D.S.; Carpenter, K.A.; Jarrell, J.T.; Huang, X. Deep learning-based classification of multi-categorical Alzheimer’s disease data. Curr. Neurobiol., 2019, 10(3), 141-147.
[PMID: 31798274]
[57]
Chen, L.; Qiao, H.; Zhu, F. Alzheimer’s disease diagnosis with brain structural MRI using multiview-slice attention and 3D convolution neural network. Front. Aging Neurosci., 2022, 14, 871706.
[http://dx.doi.org/10.3389/fnagi.2022.871706] [PMID: 35557839]
[58]
Ebrahimi, A.; Luo, S. Disease Neuroimaging Initiative, A. Convolutional neural networks for Alzheimer’s disease detection on MRI images. J. Med. Imaging (Bellingham), 2021, 8(2), 024503.
[http://dx.doi.org/10.1117/1.JMI.8.2.024503] [PMID: 33937437]
[59]
Qiao, H.; Chen, L.; Zhu, F. A Fusion of multi-view 2D and 3D convolution neural network based MRI for Alzheimer’s disease diagnosis. In: 2021 43rd Annual International Conference of the IEEEEngineering in Medicine & Biology Society (EMBC);, IEEE: Mexico2021, pp. 3317-3321.
[http://dx.doi.org/10.1109/EMBC46164.2021.9629923]
[60]
Zhang, J.; Zheng, B.; Gao, A.; Feng, X.; Liang, D.; Long, X. A 3D densely connected convolution neural network with connection-wise attention mechanism for Alzheimer’s disease classification. Magn. Reson. Imaging, 2021, 78, 119-126.
[http://dx.doi.org/10.1016/j.mri.2021.02.001] [PMID: 33588019]
[61]
Liu, S.; Masurkar, A.V.; Rusinek, H.; Chen, J.; Zhang, B.; Zhu, W.; Fernandez-Granda, C.; Razavian, N. Generalizable deep learning model for early Alzheimer’s disease detection from structural MRIs. Sci. Rep., 2022, 12(1), 17106.
[http://dx.doi.org/10.1038/s41598-022-20674-x] [PMID: 36253382]
[62]
Venugopalan, J.; Tong, L.; Hassanzadeh, H.R.; Wang, M.D. Multimodal deep learning models for early detection of Alzheimer’s disease stage. Sci. Rep., 2021, 11(1), 3254.
[http://dx.doi.org/10.1038/s41598-020-74399-w] [PMID: 33547343]
[63]
Qasim Abbas, S.; Chi, L.; Chen, Y-P.P. Transformed domain convolutional neural network for Alzheimer’s disease diagnosis using structural MRI. Pattern Recognit., 2023, 133, 109031.
[http://dx.doi.org/10.1016/j.patcog.2022.109031]
[64]
Xu, X.; Lin, L.; Sun, S.; Wu, S. A review of the application of three-dimensional convolutional neural networks for the diagnosis of Alzheimer’s disease using neuroimaging. Rev. Neurosci., 2023, 34(6), 649-670.
[http://dx.doi.org/10.1515/revneuro-2022-0122] [PMID: 36729918]
[65]
Montesinos López, O.A.; Montesinos López, A.; Crossa, J. Fundamentals of artificial neural networks and deep learning. In: Multivariate Statistical Machine Learning Methods for Genomic Prediction; Springer: Cham, 2022; pp. 379-425.
[http://dx.doi.org/10.1007/978-3-030-89010-0_10]
[66]
Zhang, F.; Tian, S.; Chen, S.; Ma, Y.; Li, X.; Guo, X. Voxel-based morphometry: Improving the diagnosis of Alzheimer’s disease based on an extreme learning machine method from the ADNI cohort. Neuroscience, 2019, 414, 273-279.
[http://dx.doi.org/10.1016/j.neuroscience.2019.05.014] [PMID: 31102761]
[67]
Ning, K.; Chen, B.; Sun, F.; Hobel, Z.; Zhao, L.; Matloff, W.; Toga, A.W. Classifying Alzheimer’s disease with brain imaging and genetic data using a neural network framework. Neurobiol. Aging, 2018, 68, 151-158.
[http://dx.doi.org/10.1016/j.neurobiolaging.2018.04.009] [PMID: 29784544]
[68]
Mendoza-Léon, R.; Puentes, J.; Uriza, L.F.; Hernández Hoyos, M. Single-slice Alzheimer’s disease classification and disease regional analysis with supervised switching autoencoders. Comput. Biol. Med., 2020, 116, 103527.
[http://dx.doi.org/10.1016/j.compbiomed.2019.103527] [PMID: 31765915]
[69]
Mehdipour, G.M.; Nielsen, M.; Pai, A.; Cardoso, M.J.; Modat, M.; Ourselin, S.; Sørensen, L. Training recurrent neural networks robust to incomplete data: Applications to Alzheimer’s disease progression modeling. Med. Image Anal., 2019, 53, 39-46.
[http://dx.doi.org/10.1016/j.media.2019.01.004] [PMID: 30682584]
[70]
Matlani, P. BiLSTM-ANN: early diagnosis of Alzheimer’s disease using hybrid deep learning algorithms. Multimedia Tools Appl., 2024, 83(21), 60761-60788.
[http://dx.doi.org/10.1007/s11042-023-17867-5]
[71]
Park, H.J.; Lee, J.Y.; Yang, J.J.; Kim, H.J.; Kim, Y.S.; Kim, J.Y.; Choi, Y.Y. Prediction of amyloid β-positivity with both MRI parameters and cognitive function using machine learning. Daehan Yeongsang Uihakoeji, 2023, 84(3), 638-652.
[http://dx.doi.org/10.3348/jksr.2022.0084] [PMID: 37325007]
[72]
Suk, H.I.; Lee, S.W.; Shen, D. Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis. Neuroimage, 2014, 101, 569-582.
[http://dx.doi.org/10.1016/j.neuroimage.2014.06.077] [PMID: 25042445]
[73]
Ju, R.; Hu, C.; Zhou, P.; Li, Q. Early diagnosis of Alzheimer’s disease based on resting-state brain networks and deep learning. IEEE/ACM Trans. Comput. Biol. Bioinformatics, 2019, 16(1), 244-257.
[http://dx.doi.org/10.1109/TCBB.2017.2776910] [PMID: 29989989]
[74]
Nguyen, D.T.; Ryu, S.; Qureshi, M.N.I.; Choi, M.; Lee, K.H.; Lee, B. Hybrid multivariate pattern analysis combined with extreme learning machine for Alzheimer’s dementia diagnosis using multi-measure rs-fMRI spatial patterns. PLoS One, 2019, 14(2), e0212582.
[http://dx.doi.org/10.1371/journal.pone.0212582] [PMID: 30794629]
[75]
Amoroso, N.; Diacono, D.; La Rocca, M.; Bellotti, R.; Tangaro, S. Salient networks: A novel application to study Alzheimer disease. Biomed. Eng. Online, 2018, 17(Suppl. 1), 162.
[http://dx.doi.org/10.1186/s12938-018-0566-5] [PMID: 30458801]
[76]
Yang, S.T.; Lee, J.D.; Chang, T.C.; Huang, C.H.; Wang, J.J.; Hsu, W.C.; Chan, H.L.; Wai, Y.Y.; Li, K.Y. Discrimination between Alzheimer’s disease and mild cognitive impairment using SOM and PSO-SVM. Comput. Math. Methods Med., 2013, 2013, 1-10.
[http://dx.doi.org/10.1155/2013/253670] [PMID: 23737859]
[77]
Mukhtar, G.; Farhan, S. Convolutional neural network based prediction of conversion from mild cognitive impairment to Alzheimer’s disease: A technique using hippocampus extracted from MRI. Adv. Electr. Comput. Eng., 2020, 20(2), 113-122.
[http://dx.doi.org/10.4316/AECE.2020.02013]
[78]
Lian, C.; Liu, M.; Zhang, J.; Shen, D. Hierarchical fully convolutional network for joint atrophy localization and Alzheimer’s disease diagnosis using structural MRI. IEEE Trans. Pattern Anal. Mach. Intell., 2020, 42(4), 880-893.
[http://dx.doi.org/10.1109/TPAMI.2018.2889096] [PMID: 30582529]
[79]
Barbaroux, H.; Feng, X.; Yang, J.; Laine, A.F.; Angelini, E.D. Encoding human cortex using spherical CNNs: A study on Alzheimer’s disease classification. 2020 IEEE 17th International Symposium on Biomedical Imaging (ISBI), 2020.
[http://dx.doi.org/10.1109/ISBI45749.2020.9098353]

Rights & Permissions Print Cite